Sex, Psychopharmacology, and Diabetes (SECRET)
Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Diabetes Mellitus
About this trial
This is an interventional supportive care trial for Schizophrenia focused on measuring Randomized Controlled Trial, Treatment Adherence and Compliance, Antipsychotic Agents, Patient Education as Topic
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years A diagnosis in the schizophrenic spectrum (ICD10 F2x) A diagnosis of diabetes (ICD10 E10x, E11x, E12x, E13x, 14x) or prediabetes defined as an HbA1c between 39-47 mmol/mol (both included) measured in at least two blood samples collected with ≥3 months interval as part of the patients routine clinical monitoring Ongoing treatment with at least one antipsychotic agent Complaints about SD that can be rated using Changes in Sexual Function Questionnaire-14 (CSFQ-14) Exclusion Criteria: • Incapacitated or subject to mental health probation
Sites / Locations
- Assertive Community CentresRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
No Intervention
INT1: Only patients are educated
INT2: Only Healthcare Professionals are educated
INT3: Both patients and Healthcare Professionals are educated
Control